Way back in December, I mentioned GlycoFi. Well, they're Merck now. One of the interesting things about GlycoFi is that they are based in Lebanon, NH, which is not exactly what one would call a biotech hub. It supports my contention that a specific geographic location is NOT a prerequisite for good technology, good companies, and value creation.
GlycoFi has raised $35 million over 4 rounds of financing.
Merck to buy GlycoFi
Pharmaceutical company Merck & Co. Inc. said Tuesday it agreed to acquire GlycoFi Inc., a privately held biotechnology company, for $400 million in cash.
Comments